Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Biomarkers / HSD17B10



This biomarker is also known as:
  • Type II HADH,
  • mitochondrial RNase P subunit 2,
  • SCHAD,
  • hydroxyacyl-Coenzyme A dehydrogenase, type II, hydroxyacyl-Coenzyme A dehydrogenase, type II,
  • EC,EC,
  • HCD2,
  • amyloid-beta peptide binding alcohol dehydrogenase,
  • short chain dehydrogenase/reductase family 5C, member 1,
  • short chain L-3-hydroxyacyl-CoA dehydrogenase type 2,
  • AB-binding alcohol dehydrogenase,
  • Short-chain type dehydrogenase/reductase XH98G2,
  • MRX17,
  • MRPP2,
  • MHBD,
  • short chain type dehydrogenase/reductase XH98G2,
  • hydroxysteroid (17-beta) dehydrogenase 10,
  • SDR5C1,
  • DUPXp11.22,
  • mental retardation, X-linked, syndromic 10,
  • HADH2,
  • 3-hydroxyacyl-CoA dehydrogenase type-2,
  • 17-beta-hydroxysteroid dehydrogenase 10,
  • Mitochondrial RNase P protein 2,
  • Mitochondrial ribonuclease P protein 2,
  • ERAB,
  • 17-beta-HSD 10,
  • endoplasmic reticulum-associated amyloid beta-peptide-binding protein,
  • Endoplasmic reticulum-associated amyloid beta-peptide-binding protein,
  • MRXS10,
  • mitochondrial ribonuclease P protein 2,
  • XH98G2,
  • CAMR,
  • MRX31,
  • 3-hydroxy-2-methylbutyryl-CoA dehydrogenase,
  • ABAD,
  • 3-hydroxyacyl-CoA dehydrogenase type II,
  • 17b-HSD10,


HSD17B10, hydroxysteroid (17-beta) dehydrogenase 10, is a member of the short-chain dehydrogenase/reductase superfamily. HSD17B10 functions in mitochondrial tRNA maturation and catalyzes the oxidation of a wide variety of fatty acids, alcohols, and steroids. The protein is thought to play a role in the development of Alzheimer's disease. There are several alternatively spliced transcript variants, of which only two have been fully sequenced.


QA State: Curated
Type: Protein
Short Name:
HGNC Name: HSD17B10


There are no datasets associated with this biomarker.


The following organs have data associated with this biomarker…



Phase: Two
QA State: Under Review


No additional breast data is available.

Performance Comment

HSD17B10 was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.


This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at if you should have access to this biomarker.


Mutation Statistics

Gene Name: HSD17B10
UniProt Accession #: Q99714
Mutated Sites Count: 28
Associated Pubmed ID Count 0
CancerDO Count 11
Affected Protein Function Sites Count: 3

View in BioMuta